A genome-wide analysis of human IBD samples (both CD and ulcerative colitis [UC]) shows reduced expression of guanylin and GC-C in diseased tissues with active inflammation, implying that GC-C plays a role in this disease [187]. The gene discussed is GUCA2A; the disease is irritable bowel syndrome.